1. Home
  2. PKE vs SPRY Comparison

PKE vs SPRY Comparison

Compare PKE & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park Aerospace Corp.

PKE

Park Aerospace Corp.

HOLD

Current Price

$35.76

Market Cap

796.7M

Sector

Industrials

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$5.75

Market Cap

788.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PKE
SPRY
Founded
1954
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
796.7M
788.5M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
PKE
SPRY
Price
$35.76
$5.75
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$40.00
AVG Volume (30 Days)
308.5K
2.0M
Earning Date
05-15-2026
05-11-2026
Dividend Yield
1.53%
N/A
EPS Growth
93.10
N/A
EPS
0.17
N/A
Revenue
N/A
$84,278,000.00
Revenue This Year
N/A
$87.40
Revenue Next Year
N/A
$81.64
P/E Ratio
$201.41
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.25
$5.76
52 Week High
$39.86
$18.50

Technical Indicators

Market Signals
Indicator
PKE
SPRY
Relative Strength Index (RSI) 55.13 22.69
Support Level $31.16 N/A
Resistance Level $36.51 $8.61
Average True Range (ATR) 2.08 0.45
MACD 0.01 -0.19
Stochastic Oscillator 49.76 0.19

Price Performance

Historical Comparison
PKE
SPRY

About PKE Park Aerospace Corp.

Park Aerospace Corp is an aerospace company that develops and manufactures composite materials used to produce composite structures for the aerospace market. Its products include film adhesives, lightning strike protection materials, specialty ablative materials for rocket motors and nozzles, and materials for radome applications. The Company offers composite materials designed for hand lay-up and automated fiber placement (AFP) manufacturing applications, which are used in jet engines, large and regional transport aircraft, military aircraft, unmanned aerial vehicles (UAVs), business jets, general aviation aircraft, and rotary wing aircraft. It operates in North America, Asia, and Europe, with North America generating maximum revenue.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: